Please Wait
Applying Filters...
menu
    • menu
    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Varoglutamstat

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vivoryon Reports 2025 Financials And Business Update
    Vivoryon Reports 2025 Financials And Business Update

    23 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/23/3279553/0/en/vivoryon-therapeutics-n-v-reports-full-year-2025-financial-results-and-provides-business-update.html

    GLOBENEWSWIRE
    23 Apr 2026
    Share Share
    Vivoryon Updates Glutaminyl Cyclases As Key Targets In DKD
    Vivoryon Updates Glutaminyl Cyclases As Key Targets In DKD

    28 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/28/3264170/0/en/Vivoryon-Therapeutics-N-V-Provides-Update-on-Growing-Body-of-Evidence-Validating-Glutaminyl-Cyclases-as-Promising-Targets-in-DKD-at-World-Congress-of-Nephrology.html

    GLOBENEWSWIRE
    28 Mar 2026
    Share Share
    Vivoryon Presents Phase 2 Kidney Data At ASN Kidney Week 2025
    Vivoryon Presents Phase 2 Kidney Data At ASN Kidney Week 2025

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3182889/0/en/Vivoryon-Therapeutics-N-V-Presents-Phase-2-Kidney-Function-and-Biomarker-Data-at-the-American-Society-of-Nephrology-Kidney-Week-2025.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Vivoryon Therapeutics N.V. Expands IP with New US Patent
    Vivoryon Therapeutics N.V. Expands IP with New US Patent

    27 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/27/3088321/0/en/Vivoryon-Therapeutics-N-V-Expands-Intellectual-Property-Portfolio-with-New-U-S-Composition-of-Matter-Patent-Granted-for-Varoglutamstat.html

    GLOBENEWSWIRE
    27 May 2025
    Share Share
    Vivoryon Therapeutics N.V. Shares Highlights from R&D Update
    Vivoryon Therapeutics N.V. Shares Highlights from R&D Update

    19 Feb 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/02/19/3029027/0/en/Vivoryon-Therapeutics-N-V-Shares-Highlights-from-Virtual-R-D-Update-with-KOL-Speakers.html

    GLOBENEWSWIRE
    19 Feb 2025
    Share Share
    Vivoryon's Ph 2 Data Supporting Varoglutamstat’s Kidney Function
    Vivoryon's Ph 2 Data Supporting Varoglutamstat’s Kidney Function

    08 Dec 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/12/09/2993442/0/en/Vivoryon-Therapeutics-N-V-Presents-Topline-Phase-2-Data-from-VIVA-MIND-Strongly-Supporting-Varoglutamstat-s-Potential-to-Improve-Kidney-Function.html

    GLOBENEWSWIRE
    08 Dec 2024
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.